Literature DB >> 22904683

Identification of cell surface targets through meta-analysis of microarray data.

Henry Haeberle1, Joel T Dudley, Jonathan T C Liu, Atul J Butte, Christopher H Contag.   

Abstract

High-resolution image guidance for resection of residual tumor cells would enable more precise and complete excision for more effective treatment of cancers, such as medulloblastoma, the most common pediatric brain cancer. Numerous studies have shown that brain tumor patient outcomes correlate with the precision of resection. To enable guided resection with molecular specificity and cellular resolution, molecular probes that effectively delineate brain tumor boundaries are essential. Therefore, we developed a bioinformatics approach to analyze micro-array datasets for the identification of transcripts that encode candidate cell surface biomarkers that are highly enriched in medulloblastoma. The results identified 380 genes with greater than a two-fold increase in the expression in the medulloblastoma compared with that in the normal cerebellum. To enrich for targets with accessibility for extracellular molecular probes, we further refined this list by filtering it with gene ontology to identify genes with protein localization on, or within, the plasma membrane. To validate this meta-analysis, the top 10 candidates were evaluated with immunohistochemistry. We identified two targets, fibrillin 2 and EphA3, which specifically stain medulloblastoma. These results demonstrate a novel bioinformatics approach that successfully identified cell surface and extracellular candidate markers enriched in medulloblastoma versus adjacent cerebellum. These two proteins are high-value targets for the development of tumor-specific probes in medulloblastoma. This bioinformatics method has broad utility for the identification of accessible molecular targets in a variety of cancers and will enable probe development for guided resection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22904683      PMCID: PMC3421962          DOI: 10.1593/neo.12634

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  23 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

Authors:  Philip Stephens; Sarah Edkins; Helen Davies; Chris Greenman; Charles Cox; Chris Hunter; Graham Bignell; Jon Teague; Raffaella Smith; Claire Stevens; Sarah O'Meara; Adrian Parker; Patrick Tarpey; Tim Avis; Andy Barthorpe; Lisa Brackenbury; Gemma Buck; Adam Butler; Jody Clements; Jennifer Cole; Ed Dicks; Ken Edwards; Simon Forbes; Matthew Gorton; Kristian Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jonathon Hinton; David Jones; Vivienne Kosmidou; Ross Laman; Richard Lugg; Andrew Menzies; Janet Perry; Robert Petty; Keiran Raine; Rebecca Shepherd; Alexandra Small; Helen Solomon; Yvonne Stephens; Calli Tofts; Jennifer Varian; Anthony Webb; Sofie West; Sara Widaa; Andrew Yates; Francis Brasseur; Colin S Cooper; Adrienne M Flanagan; Anthony Green; Maggie Knowles; Suet Y Leung; Leendert H J Looijenga; Bruce Malkowicz; Marco A Pierotti; Bin Teh; Siu T Yuen; Andrew G Nicholson; Sunil Lakhani; Douglas F Easton; Barbara L Weber; Michael R Stratton; P Andrew Futreal; Richard Wooster
Journal:  Nat Genet       Date:  2005-05-22       Impact factor: 38.330

3.  Expression and cellular localization of fibrillin-1 in normal and pathological human liver.

Authors:  L Dubuisson; S Lepreux; P Bioulac-Sage; C Balabaud; A M Costa; J Rosenbaum; A Desmoulière
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

4.  Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

Authors:  Jacques Grill; Christian Sainte-Rose; Anne Jouvet; Jean-Claude Gentet; Odile Lejars; Didier Frappaz; François Doz; Xavier Rialland; Fabienne Pichon; Anne-Isabelle Bertozzi; Pascal Chastagner; Dominique Couanet; Jean-Louis Habrand; Marie-Anne Raquin; Marie-Cécile Le Deley; Chantal Kalifa
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

Review 5.  The role of ephrins and Eph receptors in cancer.

Authors:  Hanna Surawska; Patrick C Ma; Ravi Salgia
Journal:  Cytokine Growth Factor Rev       Date:  2004-12       Impact factor: 7.638

6.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

7.  Fibrillin-1 and -2 contain heparin-binding sites important for matrix deposition and that support cell attachment.

Authors:  Timothy M Ritty; Thomas J Broekelmann; Claudio C Werneck; Robert P Mecham
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

8.  Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors.

Authors:  Nikki Cheng; Dana Brantley; Wei Bin Fang; Hua Liu; William Fanslow; Douglas Pat Cerretti; Katrin N Bussell; Alastair Reith; Dowdy Jackson; Jin Chen
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

9.  Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.

Authors:  Anita Lal; Chad A Glazer; Holly M Martinson; Henry S Friedman; Gary E Archer; John H Sampson; Gregory J Riggins
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments.

Authors:  Rainer Breitling; Patrick Armengaud; Anna Amtmann; Pawel Herzyk
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

View more
  8 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Authors:  Andrea Martins-da-Silva; Mirella Baroni; Karina Bezerra Salomão; Pablo Ferreira das Chagas; Ricardo Bonfim-Silva; Lenisa Geron; Gustavo Alencastro Veiga Cruzeiro; Wilson Araújo da Silva; Carolina Alves Pereira Corrêa; Carlos Gilberto Carlotti; Rosane Gomes de Paula Queiroz; Suely Kazue Nagahashi Marie; Silvia Regina Brandalise; José Andrés Yunes; Carlos Alberto Scrideli; Elvis Terci Valera; Luiz Gonzaga Tone
Journal:  Cell Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.046

Review 3.  Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines.

Authors:  Guangxu Jin; Stephen T C Wong
Journal:  Drug Discov Today       Date:  2013-11-14       Impact factor: 7.851

4.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 5.  Eph receptors as therapeutic targets in glioblastoma.

Authors:  B W Day; B W Stringer; A W Boyd
Journal:  Br J Cancer       Date:  2014-08-21       Impact factor: 7.640

6.  Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data.

Authors:  Kelly M Robinson; Jonathan Crabtree; John S A Mattick; Kathleen E Anderson; Julie C Dunning Hotopp
Journal:  Microbiome       Date:  2017-01-25       Impact factor: 14.650

Review 7.  A review of computational drug repurposing.

Authors:  Kyungsoo Park
Journal:  Transl Clin Pharmacol       Date:  2019-06-28

8.  Comparative study of joint analysis of microarray gene expression data in survival prediction and risk assessment of breast cancer patients.

Authors:  Haleh Yasrebi
Journal:  Brief Bioinform       Date:  2015-10-26       Impact factor: 11.622

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.